Ryan M. Murphy
University of North Carolina at Chapel Hill
13 Papers
3 Citations
Ryan M. Murphy is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Biology & Gene. The author has an hindex of 5, co-authored 8 publications. Previous affiliations of Ryan M. Murphy include University of California, San Francisco.
Chat about Author
Papers
Metformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancer
Igor Vujic,Martina Sanlorenzo,Martina Sanlorenzo,Christian Posch,Rosaura Esteve-Puig,Adam J. Yen,Andrew Kwong,Aaron Tsumura,Ryan M. Murphy,Klemens Rappersberger,Susana Ortiz-Urda +10 more
TL;DR: It is shown that both of the main downstream cascades of NRAS can be blocked by this combination: metformin indirectly inhibits the PI3K/AKT/mTOR pathway and trametinib directly impedes the MAPK pathway.
A piggyBac-based toolkit for inducible genome editing in mammalian cells.
Megan D. Schertzer,Eliza Thulson,Keean C.A. Braceros,David M Lee,Emma R Hinkle,Ryan M. Murphy,Susan O Kim,Eva C.M. Vitucci,J. Mauro Calabrese +8 more
TL;DR: It is shown that CRISPR-Bac can be used to knock down proteins of interest, to create targeted genetic deletions with high efficiency, and to activate or repress transcription of protein-coding genes and an imprinted long noncoding RNA.
Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.
Igor Vujic,Martina Sanlorenzo,Rosaura Esteve-Puig,Marin Vujic,Andrew Kwong,Aaron Tsumura,Ryan M. Murphy,Adrian Moy,Christian Posch,Babak Monshi,Klemens Rappersberger,Susana Ortiz-Urda +11 more
TL;DR: This work investigates the expression and function of NRAS depalmitoylating acyl protein thioesterases 1 and 2 and concludes that palmostatin B has effects on NRAS downstream signaling and cell viability in NRAS mutant melanoma cells, offering an interesting starting point for future studies.
37
Lysyl hydroxylase 2-induced collagen cross-link switching promotes metastasis in head and neck squamous cell carcinomas.
Kotaro Sato,Kshitij Parag-Sharma,Masahiko Terajima,Adele M. Musicant,Ryan M. Murphy,Matthew R. Ramsey,Hideharu Hibi,Mitsuo Yamauchi,Antonio L. Amelio +8 more
TL;DR: It is found that LH2 overexpression dramatically increases HNSCC cell migratory and invasive abilities in vitro and that LH 2-driven changes in collagen cross-linking robustly induces metastasis in vivo, implicate LH2 as a key regulator of H NSCC tumor invasion and metastasis by modulating collagenCross-link quality and suggest that therapeutic strategies targeting LH2-mediated collagen cross -linking in the TME may be effective in controlling tumor progression and improving disease outcomes.
22
Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor
Tigist Y. Tamir,Brittany M. Bowman,Megan J. Agajanian,Dennis Goldfarb,Travis P. Schrank,Trent Stohrer,Andrew E. Hale,Priscila F. Siesser,Seth J. Weir,Ryan M. Murphy,Kyle M. LaPak,Bernard E. Weissman,Nathaniel J. Moorman,M. Ben Major +13 more
TL;DR: The catalytically active BRSK2 kinase is established as a negative regulator of NRF2 via the AMPK/mTOR signaling, which may prove useful for therapeutically targetingNRF2 in human diseases.
12